Sign In
4 Jun 2018 16:15
Persons Discharging Managerial Responsibilities / persons closely associated with them (PDMR) Notification
4 June 2018: Circassia Pharmaceuticals plc (LSE: CIR).
1 - Details of the person discharging managerial responsibilities/person closely associated
Name | Rod Hafner |
2 - Reason for the notification
Position/status | Director and Senior Vice President Research & Development (PDMR) |
Initial notification/amendment* | Initial Notification |
In case of amendment, please enter the previous notification reference number and explain the error that this notification needs amending | N/A |
3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Full name of entity* | Circassia Pharmaceuticals plc |
Legal Entity Identifier code | 2138006YAT138TOGA556 |
In accordance with ISO 1744 LEI code |
4 - Details of the transaction(s)
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
Date | Description of Financial Transaction | Aggregated Price | Aggregated Volume | Total Aggregated Price |
31-May-18 | Grant of options under the 2018 Share Option scheme. | £0.0008 | 250,000 | £200 |
i. Award of options
Description of the financial instrument, type of instrument | Circassia Pharmaceuticals Plc 2018 Performance Share Plan | ||||||
Identification Code | N/A | ||||||
Nature of the transaction | Award of options | ||||||
Currency | GBP | ||||||
Price(s) and Volume (s) |
| ||||||
Aggregated Information |
| ||||||
Date of Transaction | 31 May 2018 | ||||||
Place of Transaction | London: XLON |
For further information, please contact:
| |
Circassia Pharmaceuticals plc Julien Cotta, Company Secretary |
+44 (0) 1865 405560 |
Follow the stocks
